Clinical Report: Association of Soluble fms-like Tyrosine Kinase-1 with PPCM

Overview

This exploratory meta-analysis evaluates the association between soluble fms-like tyrosine kinase-1 (sFlt-1) levels and peripartum cardiomyopathy (PPCM). Elevated sFlt-1 levels are linked to increased PPCM risk, particularly in women with pre-eclampsia, although diagnostic performance remains modest.

Background

Peripartum cardiomyopathy (PPCM) is a rare but serious form of heart failure that occurs during late pregnancy or shortly after delivery. The identification of reliable biomarkers for PPCM is crucial for risk stratification and early diagnosis. Soluble fms-like tyrosine kinase-1 (sFlt-1) has been implicated in PPCM and may provide valuable diagnostic insights, especially in the context of pre-eclampsia.

Data Highlights

Key Findings

• High sFlt-1 levels are associated with increased risk of PPCM.
• Pooled odds ratio for PPCM risk with high sFlt-1 is 1.79.
• In women with pre-eclampsia, the association with PPCM is stronger (OR 2.11).
• Diagnostic performance of sFlt-1 shows sensitivity of 72% and specificity of 57%.
• Exploratory analyses indicate better diagnostic discrimination in women with pre-eclampsia.

Clinical Implications

The findings suggest that elevated sFlt-1 levels may serve as a potential biomarker for assessing PPCM risk, particularly in women with pre-eclampsia. However, the modest diagnostic performance indicates that sFlt-1 should not be used for antepartum screening until further studies validate its clinical utility.

Conclusion

Reinforce the need for additional research and clinical application considerations.

Related Resources & Content

1. Frontiers, Source, 2026 -- Soluble fms-like tyrosine kinase-1 and peripartum cardiomyopathy: an exploratory meta-analysis of association and diagnostic performance
2. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | European Heart Journal | Oxford Academic
3. Peripartum Cardiomyopathy Review: Key Points - American College of Cardiology
4. npj Digital Medicine — Development and validation of a machine learning-based scoring system to assess the diagnostic efficacy of endomyocardial biopsy
5. Clinical Research in Cardiology — The Role of Gut Microbiota-Derived Trimethylamine N-oxide (TMAO) in Cardiovascular Risk Among Patients with Suspected Functionally Relevant Coronary Artery Disease (fCAD)
6. European Journal of Preventive Cardiology — Risk assessment and prevention in cardiomyopathies
7. Clinical Research in Cardiology — Evaluating the Novel CMR Metric "Myocardial Transit Time" (MyoTT) for Identifying Microvascular Alterations in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
8. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | European Heart Journal | Oxford Academic
9. Peripartum Cardiomyopathy Review: Key Points - American College of Cardiology
10. Frontiers | Soluble fms-like tyrosine kinase-1 and peripartum cardiomyopathy: an exploratory meta-analysis of association and diagnostic performance